SAN DIEGO, Sept. 11, 2018 /PRNewswire/ — Seqster the leading consumer-centric health data management platform empowering employees, members, or patients to collect, own and share all of their health data, today joined the American Heart Association’s Center for Health Technology and Innovation (CHTI) Health Tech Collaborative. The collaboration will combine AHA’s data-driven approaches with Seqster’s […]
Coronary/Structural Heart
Paragonix Technologies, Inc., Announces Clinical Use of the Paragonix SherpaPak™ Cardiac Transport System in World-Renowned Transplant Centers
BRAINTREE, Mass.–(BUSINESS WIRE)–Paragonix Technologies, Inc., a Boston-based commercial-stage medical device company, announced today, a successful series of clinical use, of the Paragonix SherpaPak™ Cardiac Transport System (CTS) at a leading Boston-based hospital and other world-renowned transplant centers in the United States and in Europe. The Paragonix SherpaPak™ CTS1,2 is intended for […]
LivaNova Welcomes NICE Interventional Procedures Guidance on Sutureless Aortic Valve Replacement
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, welcomes the recently updated interventional procedures guidance for sutureless aortic valve replacement issued by the U.K. National Institute for Health and Care Excellence (NICE), which states that sutureless aortic valve replacement is an alternative to conventional surgical aortic valve replacement. The […]
Ancora Heart Announces Key Activities for Transcatheter Cardiovascular Therapeutics 2018
SANTA CLARA, Calif.–(BUSINESS WIRE)–Ancora Heart, Inc., a company developing a novel therapy to address heart failure, today announced the company’s key activities at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation in San Diego. Interim data will be presented from the recently expanded […]
ImpediMed SOZO® Abstract Presentations at Key Scientific Cardiology Meetings Demonstrate Utilization of Bioimpedance Spectroscopy for Heart Failure Patients
BRISBANE, Australia & CARLSBAD, Calif.–(BUSINESS WIRE)–ImpediMed Limited (ASX: IPD), a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), announces that two abstracts demonstrating utilization of its SOZO® device will be presented during poster presentations by A.J. Accardi, M.D. at the upcoming American […]
Millipede, Inc. Announces First Implants with New Integrated ICE Delivery System
SANTA ROSA, Calif., Sept. 10, 2018 /PRNewswire/ — Millipede, Inc., a medical device company leading the way in adding to the structural heart toolbox for the interventional cardiologist, has successfully treated two patients utilizing its latest-generation delivery system which incorporates a fully integrated intracardiac echocardiography (ICE) catheter. The catheter was designed to […]
Medtronic Announces One-Month DAPT Clinical Study in the U.S. and Japan with Resolute Onyx DES in High Bleeding Risk Patients
(GLOBE NEWSWIRE via COMTEX) —The Onyx ONE Clear Study Builds Upon Body of Clinical Evidence to Inform Individualized DAPT Duration Following Stent Procedures DUBLIN – September 10, 2018 – Medtronic plc (NYSE:MDT) today announced the start of the Onyx ONE Clear Study in the U.S. and Japan that will evaluate one-month […]
New Report from Vizient Evaluates “MRI-compatible” Cardiac Rhythm Devices
IRVING, Texas–(BUSINESS WIRE)–Vizient, Inc. today released its report “The Beat Goes On: Weighing Clinical Benefits, Patient Selection and Healthcare Economics of MRI-Compatible Cardiac Rhythm Devices”, which discusses the financial impact to hospitals resulting from the sudden and dramatic increase in the use of MRI-compatible CRM devices over the last 18 months. Magnetic resonance imaging (MRI)-compatible […]
Gore Completes Patient Enrollment in U.S. Pivotal Clinical Study of GORE® CARDIOFORM ASD Occluder
FLAGSTAFF, Ariz.–(BUSINESS WIRE)–W. L. Gore & Associates, Inc. (Gore) has completed enrollment for the pivotal phase of the Gore ASSURED Clinical Study. This investigational device exemption (IDE) trial is researching the new GORE®CARDIOFORM ASD Occluder for the interventional closure of Atrial Septal Defects (ASDs), sized 8 to 35 mm. The […]
SentreHEART Announces 400th Patient Enrollment in the Landmark aMAZE Trial
REDWOOD CITY, Calif.–(BUSINESS WIRE)–SentreHEART, Inc., manufacturer of the LARIAT® Suture Delivery Device (LARIAT) for percutaneous left atrial appendage (LAA) closure announces enrollment of the 400th patient in the prospective, multi-center, randomized controlled Trial known as the aMAZE Trial. The Trial is a superiority design and intends to demonstrate the LARIAT procedure […]



